Banner
Pilot Study: Fibromyalgia Fatigue Improved By TENS Therapy

Fibromyalgia is the term for a poorly-understood condition where people experience pain and fatigue...

High Meat Consumption Linked To Lower Dementia Risk

Older people who eat large amounts of meat have a lower risk of dementia and cognitive decline...

Long Before The Inca Colonized Peru, Natives Had A Thriving Trade Network

A new DNA analysis reveals that long before the Incan Empire took over Peru, animals were...

Mesolithic People Had Meals With More Tradition Than You Thought

The common imagery of prehistoric people is either rooting through dirt for grubs and picking berries...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

Researchers have been able to watch the interior cells of a plant synthesize cellulose for the first time by tricking the cells into growing on the plant's surface.

"The bulk of the world's cellulose is produced within the thickened secondary cell walls of tissues hidden inside the plant body," says University of British Columbia Botany PhD candidate Yoichiro Watanabe, lead author of the paper published this week in Science.

"So we've never been able to image the cells in high resolution as they produce this all-important biological material inside living plants."

Much like the flapping of a windsock displays the quick changes in wind's speed and direction, called turbulence, comet tails can be used as probes of the solar wind - the constant flowing stream of material that leaves the sun in all directions.

According to new studies of a comet tail observed by NASA's Solar and Terrestrial Relations Observatory, or STEREO, the vacuum of interplanetary space is filled with turbulence and swirling vortices similar to gusts of wind on Earth. Such turbulence can help explain two of the wind's most curious features: its variable nature and unexpectedly high temperatures.

Scientists engineered stem cells to better understand the mechanisms behind a form of leukemia caused by changes in a key gene.

Past work had established that inherited changes in the DNA code for the gene PTPN11 cause Noonan syndrome, a genetic disease that comes with a high risk for the blood cancer called juvenile myelomonocytic leukemia (JMML). The mechanisms behind the disease, and what influences its severity, were unknown going into the current study.

In addition, the only current treatment for JMML, a bone marrow transplant to replace the hematopoietic stem cells that become blood cells, is effective in only 50 percent of patients. This has further spurred efforts to understand related disease mechanisms as a step toward designing better treatments.

Antipsychotic drugs are initiated in patients with Alzheimer's disease (AD) more frequently than in the general population - already 2-3 years before the Alzheimer's diagnosis, according to a new study from the University of Eastern Finland. Most commonly, antipsychotics were initiated during the six months following the Alzheimer's diagnosis; however, the incidence of new antipsychotic users was high also later on. 

A new challenges prevailing wisdom by identifying the atmosphere as the driver of a decades-long climate variation known as the Atlantic Multi-decadal Oscillation (AMO) and offering new insight on the causes and predictability of natural climate variations, which are known to cause wide-ranging global weather impacts, including increased rainfall, drought, and greater hurricane frequency in many parts of the Atlantic basin.

For decades, research on climate variations in the Atlantic has focused almost exclusively on the role of ocean circulation as the main driver, specifically the Atlantic Meridional Overturning Circulation, which carries warm water north in the upper layers of the ocean and cold water south in lower layers like a large conveyor belt.

Scientists have developed a blood test that could help pair cancer patients with the most suitable therapy for their disease and then track the tumor's progress to see if the treatment is working, according to research published today (Thursday) in Clinical Cancer Research.

Using the blood test throughout a patient's treatment gives a 'running commentary' of what is happening to tumors - giving scientists the lowdown on how well the treatment is working, how the cancer is changing and whether it is becoming resistant to treatment. It is the first time a blood test has been used in this way during clinical trials of targeted drugs, proving that the technique can monitor cancer simply and quickly.